The taboo tablet
More and more string players rely on beta blockers, but few are open about using them. Catherine Nelson talks to musicians and medical experts about the drugs’ risks and benefits, and why their use is still such a sensitive subject
‘I use a beta-blocker every time I play a solo or first violin in a performing chamber group. Without it I don’t have control over my vibrato or my bow because my hands shake. I still hesitate to play solos but do not fear them as much as I used to.’
Violinist Dottie Goldfarb, from California, is just one of many players who have an intense, adverse reaction to performance stress, and for whom beta-blockers are a godsend, allowing them to conquer their fear enough to perform. A 1987 study showed that 27 per cent of US professional orchestral musicians were taking beta-blockers occasionally to control their nerves. In a US report in January this year, a senior violin tutor from the University of Minnesota School of Music suggested that between 80 and 90 per cent of professional musicians take them before orchestral auditions. Evidence is anecdotal because there have been no recent studies in the US or Europe, but the trend for musicians to reach for the beta-blockers when under extreme stress is clearly on the up.
To read the full article subscribe to The Strad Click here to subscribe
A subscription to The Strad magazine gets you closer to the best players, the finest instruments, and the most famous makers every month. If you're serious about strings, you need The Strad. Click 
The Strad
The taboo tablet
COMMENTS (3) Add Your Comment
David Fowler ( 04 August 2010)
Anna Hamilton ( 11 August 2010)
John Au ( 28 August 2010)